CytomX Therapeutics, Inc. Recorded Big Gain

Mon, Mar 16, 2026 at 07:29 PM

CytomX Therapeutics, Inc. (CTMX:NASDAQ) shot up at $6.75, representing a gain of 44.2%. On Mon, Mar 16, 2026, CTMX:NASDAQ hit a New 2-Week High of $6.75. The stock appeared on our News Catalysts scanner on Mon, Mar 16, 2026 at 06:56 PM in the 'PUBLIC OFFERING' category. From Mon, Mar 02, 2026, the stock recorded 30.00% Up Days and 45.45% Green Days

About CytomX Therapeutics, Inc. (CTMX:NASDAQ)

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.

Top 10 Gainers:

Urgent.ly Inc. (ULY:NASDAQ), 164.53%
Smart for Life, Inc. (SMFL:NASDAQ), 125%
HCW Biologics Inc. (HCWB:NASDAQ), 81.19%
AirSculpt Technologies, Inc. (AIRS:NASDAQ), 51.62%
CytomX Therapeutics, Inc. (CTMX:NASDAQ), 44.23%
Distribution Solutions Group, Inc. (DSGR:NASDAQ), 35.01%
Eightco Holdings Inc. (ORBS:NASDAQ), 34.13%
F45 Training Holdings Inc. (FXLV:NYSE), 33.33%
OPAL Fuels Inc. (OPAL:NASDAQ), 27.57%
Peraso Inc. (PRSO:NASDAQ), 25.5%